Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Published Date : Feb 2021 | No. of Pages : 250 Pages | Category : Healthcare

The global Veterinary Active Pharmaceutical Ingredients Manufacturing market size is expected to be worth around US$ 10.89 billion by 2030, according to a new report by Vision Research Reports.

The global Veterinary Active Pharmaceutical Ingredients Manufacturing market size was valued at US$ 6.5 billion in 2020 and is anticipated to grow at a CAGR of 6.11% during forecast period 2021 to 2030.

Growth Factors

The market is primarily driven by the increasing pet expenditures and number of veterinarians & veterinary visits and high prevalence of zoonotic diseases. The growing livestock population is also driving the market. According to the U.S. Department of Agriculture, there were 103.0 million cattle and 32.1 million beef cows in the U.S. in July 2020, and this number is expected to grow substantially in the coming years. Moreover, factors such as rise in R&D investments, advancements in procedures, high pet adoption rates, increased consumption of meat, and mandatory vaccination are anticipated to boost the market growth during the forecast period.

Favorable government policies are boosting the manufacturing of veterinary active pharmaceutical ingredients. For instance, initiatives, such as Pharma Vision 2020 by the Indian government, which is aimed at developing the country’s capabilities in the fields of drug discovery, innovation, and drug manufacturing, is expected to have a positive impact on the political scenario of the market. This is expected to fuel the market growth.

Report Highlights

The contract outsourcing service type accounted for the largest revenue share of over 58% in 2020 owing to the associated benefits with its adoption. Companies are outsourcing raw material procurement and manufacturing services. Moreover, this service type is gaining popularity owing to the absence of captive production capacity with small- and mid-scale pharmaceutical companies.

The in-house service type segment is estimated to register the fastest CAGR over the forecast period as this service type ensures complete control over the process and intellectual property associated with the therapy. This service type is especially popular among early-stage companies with innovative manufacturing processes or therapies that are developed by research staff or founders in the laboratory.

The chemical-based API segment dominated the global veterinary API manufacturing market with a revenue share of over 39% in 2020. This can be attributed to the high usage of these APIs by many major manufacturing companies. Also, according to Lonza, around 70 to 80% of the drugs in the market are chemical-based. Furthermore, chemical-based APIs are cost-effective as compared to biological APIs, which further drives the segment.

The HPAPI segment is projected to register the fastest CAGR from 2021 to 2028. High-potency APIs have a dosage rate of 20 to 50 times lower than the typical APIs, which boosts their demand. Favorable government regulations for R&D and commercialization of novel drug molecules are also anticipated to drive the segment. Their ability to target specific diseased cells is expected to increase their demand further.

The vaccines product segment held the largest market share of over 23% in 2020 and will expand further at a significant CAGR from 2021 to 2028. This growth can be attributed to the rising demand for vaccines due to the high prevalence of chronic diseases in animals. Furthermore, increasing livestock population & animal husbandry coupled with the commercialization of animal products is expected to boost the demand for vaccines, thereby driving the segment growth.

North America was the dominant regional market in 2020 and accounted for a revenue share of over 31%. Zoonoses are an additional threat to public health as animals are often the natural source of a disease. The high prevalence of zoonotic diseases is the key factor contributing to the market growth. Favorable reimbursement programs are fueling the demand for veterinary medicine, thereby providing a growth platform for the market in this region.

On the other hand, Asia Pacific is projected to be the fastest-growing regional market from 2021 to 2028. Market growth in the region can be attributed to the significantly high cattle population, which has enhanced the demand for meat production. China and India constitute more than 30% of the global cattle population. Moreover, in 2018, Asia Pacific accounted for 40 to 50% of the total meat production worldwide.

Key Players

  • Alivira Animal Health Ltd.

  • Excel Industries Ltd.

  • Ofichem Group

  • Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.

  • Menadiona

  • Afton Pharma

  • Jiangsu Lingyun Pharmaceutical Co., Ltd.

  • SUANFARMA

  • NGL Fine-Chem Ltd.

  • FIS - Fabbrica Italiana Sintetici S.p.A

Market Segmentation

  • Service Type Outlook 

    • In House

    • Contract Outsourcing

      • Contract Development

        • Preclinical Development

        • Others

      • Contract Manufacturing

        • API/Bulk Drugs

        • Finished Dose Formulations

  • Synthesis Type Outlook 

    • Chemical-based API

    • Biological API

    • HPAPI

  • Product Outlook 

    • Antiparasitic

    • Anti-infectives

    • NSAIDs

    • Vaccines

    • Biologics

    • Others

  • Regional Outlook 

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin Americ

      • Brazil

      • Mexico

    • Middle East and Africa (MEA)

      • Saudi Arabia

      • South Africa

The Veterinary Active Pharmaceutical Ingredients Manufacturing market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Veterinary Active Pharmaceutical Ingredients Manufacturing market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Veterinary Active Pharmaceutical Ingredients Manufacturing market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Veterinary Active Pharmaceutical Ingredients Manufacturing market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Veterinary Active Pharmaceutical Ingredients Manufacturing market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Veterinary Active Pharmaceutical Ingredients Manufacturing capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Veterinary Active Pharmaceutical Ingredients Manufacturing by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Veterinary Active Pharmaceutical Ingredients Manufacturing market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Veterinary Active Pharmaceutical Ingredients Manufacturing market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Veterinary Active Pharmaceutical Ingredients Manufacturing market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Veterinary Active Pharmaceutical Ingredients Manufacturing industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

The Veterinary Active Pharmaceutical Ingredients Manufacturing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Veterinary Active Pharmaceutical Ingredients Manufacturing market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Veterinary Active Pharmaceutical Ingredients Manufacturing market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Veterinary Active Pharmaceutical Ingredients Manufacturing market. These factors have benefited the growth of the global market for Veterinary Active Pharmaceutical Ingredients Manufacturing. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Veterinary Active Pharmaceutical Ingredients Manufacturing. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Veterinary Active Pharmaceutical Ingredients Manufacturing are as follows:

  • Historic Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Featured Research Reports

  • Featured Research Reports

    Cancer Immunotherapy Market (By Product: Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies and Cancer Vaccines; By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer, Pancreatic Cancer) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...
  • Featured Research Reports

    Women’s Health App Market (By Type: Fitness & Nutrition, Menstrual Health, Pregnancy Tracking & Postpartum Care, Menopause, Disease Management) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...
  • Featured Research Reports

    Biopharmaceutical Third Party Logistics Market (By Supply Chain: Cold Chain, Non-cold Chain; By Service Type: Transportation, Warehousing and Storage) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...
  • Featured Research Reports

    Traumatic Brain Injury Assessment & Management Devices Market (By Device: Imaging Devices, Monitoring Devices; By Technique: Intracranial Pressure (ICP) Monitoring, Partial Pressure of Oxygen in Brain Tissue (pBrO2); By End-use: Hospitals, Diagnostic Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...
  • Featured Research Reports

    Magnetic Resonance Imaging Market (By Architecture: Closed System, Open System; By Field Strength: Low Field Strength, Mid Field Strength, High Field Strength; By Application: Brain and neurological, Spine and musculoskeletal, Vascular, Abdominal, Cardiac, Breast; By End-use: Hospitals, Imaging Centers, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...